Effects of Oncological Treatment During Pregnancy on Mother and Child
University Hospital, Gasthuisberg · with The Netherlands Cancer Institute, Erasmus Medical Center · NCT00330447
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 5000
- US sites recruiting
- 1
- Study start
- August 2005
- Record last updated
- March 6, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,...) develop normally (neurologic and cardiologic examination).
Conditions: Cancer; Pregnancy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Patients do not need to participate in both; however, preferentially both study parts should be performed.
****Part I: Pregnancy, delivery and maternal health****
Patients must meet the following inclusion criteria:
- Histologically proven cancer in association with a pregnancy (during pregnancy or cancer dagnosis within 5 years after pregnancy)
- > 18 years of age, premenopausal
- Patients who have given their signed and written informed consent to participate in the trial after fully understanding the implication of the protocol
- Women receiving any cytotoxic drug or radiation therapy during pregnancy are allowed for the assessment of the maternal and fetal outcome (Part II).
Exclusion Criteria
- Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent
****Part II: Follow-up of children****
Inclusion Criteria
- Children that were prenatally exposed to cancer of cancer treament. Informed Consent is asked from parents. From the age of 12 years, informed assent is additionally asked from the child. After the age of 18 years, informed consent is solely asked of the offspring.
Exclusion Criteria
- Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent
Recruiting US locations
Cooper University Hospital (2015-ongoing)
Camden, NJ 08103
Site contact: Elyce Cardonick, MD
Study contacts (from the official record)
- Ayaka Wakatsuki · +32 16 34 41 69 · ayaka.wakatsuki@uzleuven.be
- Kristel Van Calsteren, MD PhD · +32-16-346192 · kristel.vancalsteren@uzleuven.be
Similar studies in New Jersey
All pregnancy studies in New Jersey →- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- New Brunswick, NJ + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Livingston, NJ + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Aerogen Pharma Limited
- Location
- Morristown, NJ + 17 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Princeton, NJ + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only